Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
about
PDE5 inhibitors as therapeutics for heart disease, diabetes and cancerADMET considerations for phosphodiesterase-5 inhibitors.Erectile dysfunction and its management in patients with diabetes mellitus.Partial motor restoration upon administration of sildenafil: a case study.Phosphodiesterase type 5 and cancers: progress and challenges.
P2860
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
@en
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
@nl
type
label
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
@en
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
@nl
prefLabel
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
@en
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
@nl
P2093
P2860
P1476
Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.
@en
P2093
Gary Comstock
Laurence A Levine
Robert A Kloner
Steven Tiger
Vera J Stecher
P2860
P304
P356
10.1517/14656566.2011.600306
P407
P577
2011-07-21T00:00:00Z